Clinical Trial Update: Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports on the efficacy and safety of adding DA5221-T to ongoing DA5221-B1 and DA5221-B2 therapy in adults with Type 2 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DA5221-B1
• DA5221-B2
• DA5221-T

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: ACTIVE_NOT_RECRUITING